| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.37 | 0.0004 |
| mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0005 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.84 | 0.0006 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.099 | 0.001 |